Nuvation Bio Inc (NUVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 98,897 | 247,970 | 47,977 | 35,723 | 30,036 |
| Marketable Securities | 450,148 | 359,752 | 413,699 | 466,969 | 519,099 |
| Receivables | 13,850 | 6,677 | 5,462 | 16,292 | 4,252 |
| Inventories | 5,710 | 552 | 14 | N/A | N/A |
| TOTAL | $577,530 | $623,208 | $475,567 | $526,255 | $564,985 |
| Non-Current Assets | |||||
| PPE Net | 560 | 615 | 562 | 586 | 719 |
| Intangibles | 11,680 | 12,145 | 4,410 | 4,622 | 2,779 |
| Other Non-Current Assets | 11,791 | 11,257 | 11,950 | 9,163 | 3,096 |
| TOTAL | $24,031 | $24,017 | $16,922 | $14,371 | $6,594 |
| Total Assets | $601,561 | $647,225 | $492,489 | $540,626 | $571,579 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,618 | 5,583 | 5,685 | 6,283 | 8,426 |
| Accounts payable and accrued liabilities | 15,360 | 22,419 | 10,537 | 6,348 | 12,380 |
| Accrued Expenses | 32,579 | 23,998 | 23,892 | 32,833 | 23,506 |
| Other current liabilities | 12,703 | 12,548 | 10,769 | 11,117 | 12,942 |
| TOTAL | $68,131 | $66,356 | $52,772 | $58,244 | $59,035 |
| Non-Current Liabilities | |||||
| Long Term Debt | 47,089 | 46,974 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 160,459 | 160,988 | 20,257 | 18,594 | 9,830 |
| TOTAL | $207,548 | $207,962 | $20,257 | $18,594 | $9,830 |
| Total Liabilities | $275,679 | $274,318 | $73,029 | $76,838 | $68,865 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 342,833 | 342,273 | 340,263 | 338,679 | 336,567 |
| Common Shares | 1,404,799 | 1,396,220 | 1,382,894 | 1,373,958 | 1,362,631 |
| Retained earnings | -1,078,778 | -1,022,986 | -963,979 | -910,743 | -861,298 |
| Other shareholders' equity | -139 | -327 | 545 | 573 | 1,381 |
| TOTAL | $325,882 | $372,907 | $419,460 | $463,788 | $502,714 |
| Total Liabilities And Equity | $601,561 | $647,225 | $492,489 | $540,626 | $571,579 |